Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Personalized approaches for a progressive disease

Bradford Dickerson • 5 Sep 2017
AAIC 2017
Alzheimer’s Disease

The progression of Alzheimer’s disease through different stages of impairment is increasingly recognized by experts in the field. Bradford Dickerson, MD from Massachusetts General Hospital / Harvard Medical School, Boston, MA speaks to us about the ways in which this progression can be considered to personalize clinical trials to patients, and the effect this could have on patient care and research. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.

More from Bradford Dickerson

Advancing frontotemporal dementia diagnosis through biomarkers and imaging
1:35
Advancing frontotemporal dementia diagnosis through biomarkers and imaging
Bradford Dickerson • 6 Apr 2025
Early recognition and specialist referral critical for Alzheimer's intervention
1:20
Early recognition and specialist referral critical for Alzheimer's intervention
Bradford Dickerson • 6 Apr 2025
Advances and challenges in diagnosing Alzheimer's and associated disorders
1:32
Advances and challenges in diagnosing Alzheimer's and associated disorders
Bradford Dickerson • 6 Apr 2025
Updated Alzheimer's Association clinical practice guidelines for diagnosing AD and related disorders
2:57
Updated Alzheimer's Association clinical practice guidelines for diagnosing AD and related disorders
Bradford Dickerson • 6 Apr 2025

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals